J. Jill Hopkins
Chief Medical Officer & President of Research and DevelopmentDr. J. Jill Hopkins, M.D., is Chief Medical Officer & President of Research and Development of Aura Biosciences, Inc. from October 2023. She has cross-sector experience in ophthalmology, spanning clinical care, academia, education, industry, advocacy and innovation. Dr. Hopkins served as Senior Vice President, Global Head of Ophthalmology and Exploratory Development at Novartis and Chief Executive Officer of Gyroscope Therapeutics, a Novartis company, where she was responsible for the global ophthalmic pipeline and portfolio of medicines, gene therapy, devices and digital solutions to impact eye disease and reduce visual impairment globally. Dr. Hopkins worked at Roche-Genentech in roles of increasing responsibility, most recently as Global Head Ophthalmology Personalized Health Care. Before Roche-Genentech, she worked in clinical retinal research and academic practice at the University of Toronto, University of Southern California and Retina-Vitreous Associates Medical Group. Dr. Hopkins received her M.D. from McMaster University and completed her Ophthalmology residency at the University of Toronto. She has completed fellowships in Retinal Disease from Moorfields Eye Hospital in London UK and in Visual Electrophysiology from the Universities of Toronto and Ottawa. Dr. Hopkins is board certified in Ophthalmology from the American Board of Ophthalmology and the Royal College of Surgeons Canada.
Positions
- Company NameAura Biosciences, Inc.Stock CodeAURAPositionChief Medical Officer & President of Research and DevelopmentColleagues
- DMDavid Michael JohnsonIndependent Chairman of the Board
- NCNatalie C. HollesPresident, CEO & Director
- AEAmy ElazzouziSenior Vice President of Finance, Treasurer and Secretary
- SASusan Abu-AbsiChief Operating Officer
- ADAlex DasallaHead of Investor Relations & Corporate Communications
- GMGiovanni MariggiIndependent Director
- SSSapna SrivastavaIndependent Director
- AMAntony MattessichIndependent Director
